Strategic AI for oncology Clinakos offers AI Agents and Integrated Patient Data tailored for oncology and rare diseases, presenting a targeted upsell path to life sciences companies and provider networks seeking regulatory-grade data and AI insights in niche therapeutics.

Regulatory-grade data edge Position Clinakos as a solution that provides fit-for-use, regulatory-grade patient-level data across clinical, regulatory, commercial, and medical teams, addressing a common bottleneck for sponsors and CROs in rare diseases and oncology.

Data depth advantage Highlight the claim of 10x more data per patient with no data blocking, creating a compelling differentiator for customers needing comprehensive insights, real-world evidence, and robust analytics.

Partnering opportunities Recent collaboration with Rare Patient Voice signals openness to strategic partnerships; pursue similar co-development or joint offering opportunities with patient advocacy groups, specialty clinics, and niche research consortia.

Growth-ready SMB focus With a revenue range of $1M-$10M and a lean team, Clinakos represents an attractive target for mid-market healthtech and boutique analytics firms seeking to expand capabilities in AI-powered data solutions for rare diseases and oncology.